Skip Nav Destination
Issues
15 August 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Editorials
The Biology Behind
Report from the FDA
Human Cancer Biology
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Roman Rouzier; Charles M. Perou; W. Fraser Symmans; Nuhad Ibrahim; Massimo Cristofanilli; Keith Anderson; Kenneth R. Hess; James Stec; Mark Ayers; Peter Wagner; Paolo Morandi; Chang Fan; Islam Rabiul; Jeffrey S. Ross; Gabriel N. Hortobagyi; Lajos Pusztai
WOX1 Is Essential for UVB Irradiation–Induced Apoptosis and Down-Regulated via Translational Blockade in UVB-Induced Cutaneous Squamous Cell Carcinoma In vivo
Feng-Jie Lai; Ching-Li Cheng; Shur-Tzu Chen; Chin-Han Wu; Li-Jin Hsu; J. Yu-Yun Lee; Sheau-Chiou Chao; Maw-Chang Sheen; Ching-Liang Shen; Nan-Shan Chang; Hamm-Ming Sheu
Cytochrome P450 1B1 Is Overexpressed and Regulated by Hypomethylation in Prostate Cancer
Takashi Tokizane; Hiroaki Shiina; Mikio Igawa; Hideki Enokida; Shinji Urakami; Toshifumi Kawakami; Tatsuya Ogishima; Steven T. Okino; Long-Cheng Li; Yuichiro Tanaka; Norio Nonomura; Akihiko Okuyama; Rajvir Dahiya
Cyr61 Induces Gastric Cancer Cell Motility/Invasion via Activation of the Integrin/Nuclear Factor-κB/Cyclooxygenase-2 Signaling Pathway
Ming-Tsai Lin; Chung-Yaou Zuon; Cheng-Chi Chang; Szu-Ta Chen; Chih-Ping Chen; Been-Ren Lin; Ming-Yang Wang; Yung-Ming Jeng; King-Jen Chang; Po-Huang Lee; Wei-Jao Chen; Min-Liang Kuo
Imaging, Diagnosis, Prognosis
Early Antiangiogenic Activity of SU11248 Evaluated In vivo by Dynamic Contrast-Enhanced Magnetic Resonance Imaging in an Experimental Model of Colon Carcinoma
Pasquina Marzola; Anna Degrassi; Laura Calderan; Paolo Farace; Elena Nicolato; Caterina Crescimanno; Marco Sandri; Anna Giusti; Enrico Pesenti; Andrea Terron; Andrea Sbarbati; Francesco Osculati
Activating Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor Are Associated with Improved Survival in Gefitinib-Treated Chemorefractory Lung Adenocarcinomas
Miguel Taron; Yukito Ichinose; Rafael Rosell; Tony Mok; Bartomeu Massuti; Lurdes Zamora; Jose Luis Mate; Christian Manegold; Mayumi Ono; Cristina Queralt; Thierry Jahan; Jose Javier Sanchez; Maria Sanchez-Ronco; Victor Hsue; David Jablons; Jose Miguel Sanchez; Teresa Moran
Cancer Therapy: Clinical
Pharmacokinetics of Dactinomycin in a Pediatric Patient Population: a United Kingdom Children's Cancer Study Group Study
Gareth J. Veal; Michael Cole; Julie Errington; Annie Parry; Juliet Hale; Andrew D.J. Pearson; Karen Howe; Julia C. Chisholm; Carol Beane; Bernadette Brennan; Fiona Waters; Adam Glaser; Sue Hemsworth; Heather McDowell; Yvonne Wright; Kathy Pritchard-Jones; Ross Pinkerton; Gail Jenner; James Nicholson; Ann M. Elsworth; Alan V. Boddy; UKCCSG Pharmacology Working Group
Immunologic Evaluation of Personalized Peptide Vaccination for Patients with Advanced Malignant Glioma
Naoki Yajima; Ryuya Yamanaka; Takashi Mine; Naoto Tsuchiya; Jumpei Homma; Masakazu Sano; Terukazu Kuramoto; Yayoi Obata; Nobukazu Komatsu; Yoshimi Arima; Akira Yamada; Minoru Shigemori; Kyogo Itoh; Ryuichi Tanaka
High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker with Cyclosporine to Prevent Human Anti-mouse Antibody
Carol M. Richman; Sally J. DeNardo; Robert T. O'Donnell; Aina Yuan; Sui Shen; Desiree S. Goldstein; Joseph M. Tuscano; Ted Wun; Helen K. Chew; Primo N. Lara; David L. Kukis; Arutselvan Natarajan; Claude F. Meares; Kathleen R. Lamborn; Gerald L. DeNardo
Phase 1 Trial of Flavopiridol Combined with Cisplatin or Carboplatin in Patients with Advanced Malignancies with the Assessment of Pharmacokinetic and Pharmacodynamic End Points
Keith C. Bible; Janet L. Lensing; Sacha A. Nelson; Yean K. Lee; Joel M. Reid; Matthew M. Ames; Crescent R. Isham; Jill Piens; Stacie L. Rubin; Joseph Rubin; Scott H. Kaufmann; Pamela J. Atherton; Jeffrey A. Sloan; Michelle K. Daiss; Alex A. Adjei; Charles Erlichman
Phase I and Pharmacokinetic Study of Weekly Docetaxel, Cisplatin, and Daily Capecitabine in Patients with Advanced Solid Tumors
Marwan G. Fakih; Patrick J. Creaven; Nithya Ramnath; Donald Trump; Milind Javle; Sandra Strychor; Trisha V.W. Repinski; Beth A. Zamboni; James K. Schwarz; Renee A. French; William C. Zamboni
Cancer Therapy: Preclinical
Phase I/II Combined Chemoimmunotherapy with Carcinoembryonic Antigen–Derived HLA-A2–Restricted CAP-1 Peptide and Irinotecan, 5-Fluorouracil, and Leucovorin in Patients with Primary Metastatic Colorectal Cancer
Martin R. Weihrauch; Sascha Ansén; Elke Jurkiewicz; Caroline Geisen; Zhinan Xia; Karen S. Anderson; Edith Gracien; Manuel Schmidt; Burghardt Wittig; Volker Diehl; Juergen Wolf; Heribert Bohlen; Lee M. Nadler
Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells
Aikou Okamoto; Takashi Nikaido; Kazunori Ochiai; Satoshi Takakura; Misato Saito; Yuko Aoki; Nobuya Ishii; Nozomu Yanaihara; Kyosuke Yamada; Osamu Takikawa; Rie Kawaguchi; Seiji Isonishi; Tadao Tanaka; Mitsuyoshi Urashima
Genetic Variations in the Glucocorticoid Receptor Gene Are Not Related to Glucocorticoid Resistance in Childhood Acute Lymphoblastic Leukemia
Wim J.E. Tissing; Jules P.P. Meijerink; Monique L. den Boer; Bas Brinkhof; Elisabeth F.C. van Rossum; Elisabeth R. van Wering; Jan W. Koper; Pieter Sonneveld; Rob Pieters
Response of Non–Small Cell Lung Cancer Cells to the Inhibitors of Phosphatidylinositol 3-Kinase/Akt- and MAPK Kinase 4/c-Jun NH2-Terminal Kinase Pathways: An Effective Therapeutic Strategy for Lung Cancer
Ho-Young Lee; Seung-Hyun Oh; Young-Ah Suh; Jin Hyen Baek; Vali Papadimitrakopoulou; Suyun Huang; Waun Ki Hong
Overexpression of Cyclin D1 Promotes Tumor Cell Growth and Confers Resistance to Cisplatin-Mediated Apoptosis in an Elastase-myc Transgene–Expressing Pancreatic Tumor Cell Line
Hector Biliran, Jr.; Yong Wang; Sanjeev Banerjee; Haiming Xu; Henry Heng; Archana Thakur; Aliccia Bollig; Fazlul H. Sarkar; Joshua D. Liao
Cancer Prevention
Letters to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.